Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Acne today. What's new?].

N Auffret1

  • 1Service de Dermatologie, Fondation opthalmologique Adolphe de Rothschild, Paris.

Presse Medicale (Paris, France : 1983)
|June 30, 2000
PubMed
Summary
This summary is machine-generated.

Effective acne treatment requires careful management and patient compliance. Topical therapies suffice for mild acne, while severe cases may need oral antibiotics or isotretinoin under strict medical supervision.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Inflammatory papules on the face are not always signs of acne.

Journal of the European Academy of Dermatology and Venereology : JEADV·2022
Same author

TRASS: a global approach to assess the severity of truncal acne.

Journal of the European Academy of Dermatology and Venereology : JEADV·2022
Same author

Truncal acne, what do we know?

Journal of the European Academy of Dermatology and Venereology : JEADV·2020
Same author

Acne from the young patient's perspective.

Journal of the European Academy of Dermatology and Venereology : JEADV·2019
Same author

Reply to comments made by M. Donnarumma et al. Comment on "Acne and nutrition: hypotheses, myths and facts" published by our expert group in 2018.

Journal of the European Academy of Dermatology and Venereology : JEADV·2019
Same author

Acne and nutrition: hypotheses, myths and facts.

Journal of the European Academy of Dermatology and Venereology : JEADV·2018
Same journal

Predictive analytics and risk stratification models in internal medicine: from risk scores to real-time machine learning.

Presse medicale (Paris, France : 1983)·2026
Same journal

Artificial Intelligence in skin disease therapeutics: from drug discovery to personalized treatment pathways.

Presse medicale (Paris, France : 1983)·2026
Same journal

AI in clinical diagnostics in dermatology: applications, validation, and real-world use cases.

Presse medicale (Paris, France : 1983)·2026
Same journal

Artificial Intelligence in medical research and publishing: progress, risks, and future perspectives.

Presse medicale (Paris, France : 1983)·2026
Same journal

Ethical, legal, and regulatory challenges in AI-based healthcare tools.

Presse medicale (Paris, France : 1983)·2026
Same journal

Decision-making for clinicians.

Presse medicale (Paris, France : 1983)·2026
See all related articles

Area of Science:

  • Dermatology
  • Adolescent Medicine

Context:

  • Acne vulgaris is a prevalent condition among adolescents.
  • Management requires both therapeutic intervention and psychological support.
  • Treatment duration is often prolonged, necessitating strict patient adherence.

Purpose:

  • To outline current therapeutic strategies for acne management.
  • To differentiate treatment approaches based on acne severity.
  • To highlight critical considerations for specific acne medications.

Summary:

  • Local care with retinoids, benzoyl peroxide, or topical antibiotics is suitable for retentional or inflammatory acne.
  • Severe acne necessitates a minimum 3-month oral antibiotic regimen combined with local treatments.
  • Oral isotretinoin is reserved for refractory nodular or conglobata acne, with stringent contraceptive measures for women of reproductive age due to its teratogenicity.

Related Experiment Videos

Impact:

  • Well-conducted acne treatment can lead to significant patient improvement.
  • Appropriate management strategies are crucial for optimizing therapeutic outcomes.
  • Understanding medication risks, particularly isotretinoin's teratogenicity, is vital for patient safety.